Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins

  • Authors:
    • Mouldy Sioud
    • Anne Mobergslien
    • Abdellatif Boudabous
    • Yngvar Fløisand
  • View Affiliations

  • Published online on: December 9, 2010     https://doi.org/10.3892/ijo.2010.869
  • Pages: 385-390
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Human galectins are involved in a variety of biological and pathological processes including cell adhesion, apoptosis, differentiation, immune regulation and tumour evasion. Previously, we identified galectin-3 as the first human lectin involved in the modulation of the immunosuppressive potential of mesenchymal stem cells (MSCs). In this study, we report on the expression profiles and potential activities of other galectins expressed in these cells. The data show that MSCs constitutively express galectins-1, -3 and -8 at both the mRNA and protein levels. In contrast to galectin-8, galectins-1 and -3 are secreted and found on the cell surface. MSC-mediated T cell suppression was inhibited by galectin-1-specific siRNAs but not by galectin-8-specific siRNAs. The double knockdown of galectins-1 and -3 almost abolished the immunosuppressive capacity of MSCs. The use of a competitive inhibitor for galectin binding, ß lactose, restored alloresponsiveness, implying an extracellular mechanism of action of galectins. Collectively, the data highlight the involvement of secreted galectins-1 and -3 in MSC-mediated T cell suppression. The immunosuppression by MSC-secreted galectins should facilitate the use of recombinant galectin-1 and/or -3 as a novel therapy to alleviate inflammatory reactions such as those seen in graft versus host disease (GvHD) and autoimmune disorders.

Related Articles

Journal Cover

February 2011
Volume 38 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Sioud, M., Mobergslien, A., Boudabous, A., & Fløisand, Y. (2011). Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins. International Journal of Oncology, 38, 385-390. https://doi.org/10.3892/ijo.2010.869
MLA
Sioud, M., Mobergslien, A., Boudabous, A., Fløisand, Y."Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins". International Journal of Oncology 38.2 (2011): 385-390.
Chicago
Sioud, M., Mobergslien, A., Boudabous, A., Fløisand, Y."Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins". International Journal of Oncology 38, no. 2 (2011): 385-390. https://doi.org/10.3892/ijo.2010.869